切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2022, Vol. 16 ›› Issue (02) : 136 -140. doi: 10.3877/cma.j.issn.1674-0785.2022.02.005

所属专题: 急危重症

临床研究

静注人免疫球蛋白对EV71型感染重症手足口病患儿炎症因子、免疫功能的影响
谢曼芬1,(), 高燕1, 蔡晨露1, 王肖1, 郭会敏1   
  1. 1. 570000 海口,海南省妇女儿童医学中心门急诊科
  • 收稿日期:2021-07-06 出版日期:2022-02-15
  • 通信作者: 谢曼芬
  • 基金资助:
    海南省卫生健康行业科研项目(20A200190)

Effect of human immunoglobulin injection on inflammatory factors and immune function in children with severe hand-foot-mouth disease caused by EV71 infection

Manfen Xie1,(), Yan Gao1, Chenlu Cai1, Xiao Wang1, Huimin. Guo1   

  1. 1. Department of Outdoor Emergency, Hainan Women and Children's Medical Center, Haikou 570000, China
  • Received:2021-07-06 Published:2022-02-15
  • Corresponding author: Manfen Xie
引用本文:

谢曼芬, 高燕, 蔡晨露, 王肖, 郭会敏. 静注人免疫球蛋白对EV71型感染重症手足口病患儿炎症因子、免疫功能的影响[J/OL]. 中华临床医师杂志(电子版), 2022, 16(02): 136-140.

Manfen Xie, Yan Gao, Chenlu Cai, Xiao Wang, Huimin. Guo. Effect of human immunoglobulin injection on inflammatory factors and immune function in children with severe hand-foot-mouth disease caused by EV71 infection[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(02): 136-140.

目的

探究静注人免疫球蛋白联合常规治疗肠道病毒71(EV71)型感染重症手足口病患儿疗效及对炎症因子、免疫功能的影响。

方法

选择2018年12月至2020年12月在海南省妇女儿童医学中心进行治疗的EV71型感染重症手足口病患儿126例,采用随机数字表法分为对照组和观察组,每组各63例。对照组进行常规治疗,观察组在对照组的基础上进行静注人免疫球蛋白治疗。对比2组治疗有效率、临床症状改善时间、血清炎症因子[C反应蛋白(CRP)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、白介素-17(IL-17)、白介素-10(IL-10)、生长转化因子β1(TGF-β1)]及外周血T淋巴细胞亚群水平,并观察记录不良反应发生情况。

结果

观察组临床总有效率为87.30%,高于对照组的69.84%(P<0.05);观察组体温复常时间、皮疹及口腔溃疡消退时间均短于对照组(P<0.05);治疗后,观察组血清CRP、IL-6、TNF-α、IL-17水平低于对照组(P<0.05);治疗后,观察组IL-10、TGF-β1水平高于对照组(P<0.05);治疗后,观察组CD3+、CD4+、CD4+/CD8+水平高于对照组,CD8+水平低于对照组(P<0.05);2组患儿在治疗期间未出现药物不良反应。

结论

静注人免疫球蛋白联合常规治疗EV71型感染重症手足口病患儿具有较高的临床疗效,能够促进症状恢复,可能与降低炎症反应、提高免疫功能相关。

Objective

To evaluate the efficacy of human immunoglobulin injection combined with conventional treatment in children with severe hand-foot-mouth disease caused by enterovirus 71 (EV71) infection and explore the influence on inflammatory factors and immune function.

Methods

One hundred and twenty-six children with severe hand-foot-mouth disease caused by EV71 infection who were treated at Hainan Women and Children's Medical Center between December 2018 and December 2020 were selected and divided into either a control group or an observation group using the random number table method, with 63 cases in each group. Both groups received conventional treatment, and the observation group was additionally given human immunoglobulin injection. The effective rate of treatment, time to improvement of clinical symptoms, levels of serum inflammatory factors [C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), interleukin-17 (IL-17), interleukin-10 (IL-10), and transforming growth factor β1 (TGF-β1)], and peripheral blood T lymphocyte subsets were compared between the two groups, and the occurrence of adverse reactions was recorded.

Results

The total clinical effective rate of the observation group was significantly higher than that of the control group (87.30% vs 69.84%, P<0.05). The time to normal recovery of normal body temperature and the time to disappearance of skin rash and oral ulcers in the observation group were significantly shorter than those in the control group (P<0.05). After treatment, the levels of serum CRP, IL-6, TNF-α, and IL-17 in the observation group were lower than those in the control group (P<0.05), while the levels of IL-10 and TGF-β1 were higher than those in the control group (P<0.05). After treatment, the proportions of CD3+ T cells, CD4+ T cells, and CD4+/CD8+ T cell ratio of the observation group were higher than those of the control group, while the proportion of CD8+ T cells was lower than that of the control group (P<0.05). There were no adverse drug reactions in either group during treatment.

Conclusion

Human immunoglobulin injection combined with conventional treatment has high clinical efficacy in children with severe hand-foot-mouth disease caused by EV71 infection, and can promote the recovery of symptoms, which may be related to reducing the inflammatory response and improving immune function.

表1 2组EV71型感染重症手足口病患儿一般资料比较
表2 2组患儿临床疗效比较[例(%)]
表3 2组患儿临床症状复常时间比较(d,
xˉ
±s
表4 2组患儿血清细胞因子水平比较(
xˉ
±s
表5 2组患儿T淋巴细胞亚群水平比较(
xˉ
±s
1
Esposito S, HandPrincipi N., foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention [J]. Eur J Clin Microbiol Infect Dis, 2018, 37(3): 391-398.
2
Yi EJ, Shin YJ, Kim JH, et al. Enterovirus 71 infection and vaccines [J]. Clin Exp Vaccine Res, 2017, 6(1): 4-14.
3
Luo Z, Su R, Wang W, et al. EV71 infection induces neurodegeneration via activating TLR7 signaling and IL-6 production [J]. PLoS Pathog, 2019, 15(11): e1008142.
4
孙小艳, 何涛贞, 吴琳娜, 等. 甲基强的松龙联合丙种球蛋白治疗重症手足口病对患儿血清IgM、IgG、IgA水平, 刺激分子CD80、CD86及炎症因子水平的影响 [J]. 中国煤炭工业医学杂志, 2020, 23(1): 114-118.
5
陈振, 马杰, 巩艳艳, 等. 静注人免疫球蛋白(pH4)中人肠道病毒71型中和抗体效价分析[J]. 中国生物制品学杂志, 2018, 31(1): 48-51.
6
生部手足口病临床专家组. 肠道病毒71型(EV71)感染重症病例临床救治专家共识 [J].中华儿科杂志, 2011, 49 (9) :675-678.
7
中华人民共和国卫生部. 手足口病诊治指南 [S]. 北京: 中华人民共和国卫生部, 2010.
8
Chang YK, Chen KH, Chen KT. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development [J]. Rev Inst Med Trop Sao Paulo, 2018, 60: e70.
9
唐晓芳, 童晓玲, 安阳阳. 重组人干扰素α2b喷雾剂和利巴韦林喷雾剂治疗小儿手足口病的效果比较 [J]. 川北医学院学报, 2020, 35(2): 130-132.
10
张志刚, 蔡钢. 手足口病方辅助治疗手足口病患儿的临床疗效及对细胞因子的影响研究 [J]. 中国全科医学, 2016, 19(24): 2935-2938.
11
张娟, 李丹. 早期静脉注射人免疫球蛋白治疗对重症手足口病患儿临床症状及病程的改善作用 [J]. 昆明医科大学学报, 2017, 38(3): 115-118.
12
邱良生. 人免疫球蛋白早期给药对重症手足口病患儿的临床疗效及其血清炎症因子水平的影响 [J]. 抗感染药学, 2018, 15(1): 109-111.
13
毛其芬, 崔大伟, 杨先知. 手足口病患儿细胞因子水平及免疫球蛋白的变化及其临床意义 [J]. 中国微生态学杂志, 2017, 29(3): 305-308.
14
张文良, 甘海忠, 吴飞, 等. 肠道病毒71型感染手足口病患儿Th1/Th2细胞因子变化 [J]. 中华医院感染学杂志, 2020, 30(7): 109-112.
15
戴汝均, 林冬云, 曾丽娜. 手足口病血清IL-6、TNF、CRP和NSE的临床意义 [J]. 吉林医学, 2018, 39(10): 1948-1949.
16
符日明, 陈运旺, 梁振明. 利巴韦林联合更昔洛韦对手足口病患者血清炎性细胞因子与心肌酶的影响 [J]. 湖南师范大学学报(医学版), 2020, 17(4): 90-92.
17
荣潇, 李刚, 段建飞, 等. 蒲地蓝消炎口服液对小儿手足口病免疫功能及炎性因子的影响 [J]. 中华中医药学刊, 2019, 37(3): 714-717.
18
王晓丹, 莫妙军. 手足口病患儿外周血T淋巴细胞亚群水平的变化研究 [J]. 中国社区医师, 2017, 33(20): 116-117.
[1] 李亚萍, 张萌, 李博驹, 刘晨瑞, 苟国娥, 李嘉昕, 张玉凤, 席淼, 邓慧玲. 干扰素诱导蛋白16-干扰素基因刺激因子通路在柯萨奇病毒A6型感染手足口病患儿的表达及其临床意义[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(03): 135-141.
[2] 吕巧荣, 张燕, 付敏. 232例手足口病患儿流行特征及预后风险模型的构建与验证[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(02): 91-99.
[3] 杜彦斌, 黄涛, 寇天阔, 石英. 双镜联合根治术与腹腔镜根治术在早期结肠癌患者中的应用效果[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 275-278.
[4] 鲁鑫, 杨琴, 许佳怡. 不同术式治疗恶性梗阻性黄疸疗效及对免疫功能的影响[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(02): 180-183.
[5] 杜贵伟, 陆勇, 成博, 贺薏, 梁爽. 钬激光碎石术术后联合坦索罗辛治疗对输尿管结石患者的影响分析[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(05): 491-496.
[6] 高娟, 徐建庆, 闫芳, 丁盛华, 刘霞. Rutkow、TAPP、TEP 手术治疗单侧腹股沟疝患者的临床疗效及对血清炎症因子水平的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 675-680.
[7] 刘春军, 严方方, 王宝锋, 常婷婷, 郭红红, 李志强. 替加环素联合人免疫球蛋白治疗XDRAB致VAP 的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 797-800.
[8] 邢嘉翌, 龚佳晟, 祝佳佳, 陆群. 肺癌化疗患者继发肺部感染的病原菌耐药性及炎症因子变化分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 714-718.
[9] 尹炳驿, 张楚楚, 刘艺, 林洪生. 益气清金汤加味治疗晚期非小细胞肺癌的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 462-465.
[10] 张婵, 吕瑶, 张小燕, 张鸣青. 不同时机局部神经阻滞在开腹肝切除中的镇痛效果比较[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 189-194.
[11] 戴伟川, 郭协力, 方仲宁, 蔡文华, 洪天生, 田夏阳. 显微镜下周围神经松解术治疗腰椎间盘突出症术后残余神经症状的疗效分析[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(02): 84-90.
[12] 李秀玲, 连少锋, 荣刘涛, 李登峰, 饶蕴玉. 利巴韦林联合复方嗜酸乳杆菌治疗轮状病毒肠炎患儿的临床研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 369-372.
[13] 买买提·依斯热依力, 尹强, 尹海龙, 李治建, 董雨微, 王永康, 克力木·阿不都热依木, 阿吉艾克拜尔·艾萨. 罗乐胃蜜膏抑制酸刺激诱导食管上皮细胞炎症发生的机制研究[J/OL]. 中华胃食管反流病电子杂志, 2024, 11(03): 137-142.
[14] 牟磊, 徐东成, 韩鑫, 徐长江, 韩坤锜, 薛叶潇, 牟媛, 秦文玲, 刘相静, 陈哲, 高楠. 五虫通络胶囊防治椎动脉开口支架术后再狭窄发生的效果[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 467-472.
[15] 欧春影, 李晓宾, 郭靖, 朱亮, 许可, 王梦, 安晓雷. 丁苯酞对血管性认知障碍大鼠炎症因子的影响及对认知障碍的改善作用[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 483-487.
阅读次数
全文


摘要